Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review

生酮饮食 医学 癫痫 酮症 内科学 儿科 内分泌学 精神科 糖尿病
作者
Susan Price,Todd M. Ruppar
出处
期刊:Applied Nursing Research [Elsevier]
卷期号:74: 151745-151745 被引量:3
标识
DOI:10.1016/j.apnr.2023.151745
摘要

Ketogenic therapies have shown benefit for seizure reduction in epilepsy but their impact on other neurologic conditions is less known. In this literature review, the efficacy of ketogenic therapies were assessed in Parkinson's disease (PD), Alzheimer's disease (AD), and mild cognitive impairment (MCI). A literature search was conducted using PubMed, Scopus, and Google Scholar focusing on ketogenic therapies in PD, AD, and MCI. A total of 2565 records were identified with a total of 15 studies (3 for PD and 12 for MCI/AD) meeting criteria for analysis. The ketogenic diet was used in all the PD studies and did show significant improvement in motor function either through vocal quality, gait, freezing, tremor, and/or balance. A variety of ketogenic therapies were utilized in the MCI and AD groups including a ketogenic diet, low-carbohydrate diet, modified Adkins diet, Mediterranean diet with coconut oil supplementation, a ketogenic diet with a ketogenic medium chain triglyceride (kMCT) supplement, as well as ketogenic supplements including a ketogenic drink with kMCT, oral ketogenic compounds (Axona and AC-1202), and MCT oil or emulsion. The ketogenic diet independently showed a non-significant trend towards improvement in cognition. The Mediterranean diet, modified Adkins diet, and low-carbohydrate diet showed statistically significant improvements in some, although not all, of their cognitive measures. Use of ketogenic supplements, drinks, or compounds showed variable results in the AD and MCI groups. The Axona and AC-1202 compounds showed no significant improvement in cognition at the end of their respective 90-day trials. Most MCT supplements did show cognitive improvements, although only after 6 months of adherence. Adherence to the intervention was problematic in most of the diet studies. Ketogenic therapies have promise in PD, AD, and MCI for symptom improvement although larger studies are needed to support their implementation in clinical practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
3秒前
科研通AI2S应助junru采纳,获得10
3秒前
5秒前
jackten完成签到,获得积分10
6秒前
Cheng完成签到 ,获得积分10
7秒前
锋芒不毕露完成签到,获得积分10
7秒前
yoyo完成签到 ,获得积分10
7秒前
8秒前
生如夏花完成签到 ,获得积分10
9秒前
10秒前
10秒前
13秒前
赶路人发布了新的文献求助10
14秒前
vampirell完成签到,获得积分0
15秒前
wanci应助甜甜采纳,获得10
17秒前
专注的胡萝卜完成签到 ,获得积分10
17秒前
Chaga发布了新的文献求助10
18秒前
JamesPei应助赶路人采纳,获得10
19秒前
温暖烨霖完成签到,获得积分10
19秒前
jiang发布了新的文献求助10
20秒前
Rhan完成签到,获得积分20
21秒前
24秒前
24秒前
科研通AI2S应助Rhan采纳,获得30
24秒前
周小花完成签到 ,获得积分20
25秒前
26秒前
www完成签到 ,获得积分10
27秒前
jiang完成签到,获得积分10
28秒前
甜甜发布了新的文献求助10
30秒前
现代元枫发布了新的文献求助20
30秒前
Fury发布了新的文献求助10
31秒前
陶醉觅夏发布了新的文献求助30
37秒前
画图完成签到,获得积分10
37秒前
Fury完成签到,获得积分10
38秒前
xiaoou完成签到 ,获得积分10
38秒前
AE完成签到,获得积分10
38秒前
45秒前
拜无忧发布了新的文献求助10
48秒前
支翰完成签到 ,获得积分10
52秒前
高分求助中
Sustainability in Tides Chemistry 2800
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Handbook of Qualitative Cross-Cultural Research Methods 600
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137539
求助须知:如何正确求助?哪些是违规求助? 2788516
关于积分的说明 7787054
捐赠科研通 2444818
什么是DOI,文献DOI怎么找? 1300043
科研通“疑难数据库(出版商)”最低求助积分说明 625784
版权声明 601023